Welcome to our dedicated page for Terra Innovatum Global SEC filings (Ticker: NKLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Terra Innovatum Global N.V. (NASDAQ: NKLR) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including current reports, registration statements, and exhibits related to its micro-modular nuclear reactor business. As an emerging growth company incorporated in the Netherlands and listed on The Nasdaq Stock Market LLC, Terra Innovatum files documents with the U.S. Securities and Exchange Commission that describe its corporate structure, risk factors, business combination history, and progress as a developer of the SOLO™ Micro-Modular Reactor.
Among these filings, investors can review current reports on Form 8‑K, such as disclosures about letters of intent with customers, business combination milestones, and other material events. For example, a Form 8‑K identifies Terra Innovatum Global N.V. as the registrant, confirms its Nasdaq ticker symbol NKLR, and references a press release regarding the execution of a letter of intent with a customer. Over time, the company’s quarterly and annual reports (Forms 10‑Q and 10‑K, when filed) are expected to provide more detailed information on its financial position, regulatory strategy with the U.S. Nuclear Regulatory Commission, and the status of its SOLO reactor development and commercialization plans.
On Stock Titan, these filings are complemented by AI-powered summaries designed to help readers interpret key points in lengthy documents. Users can quickly see the main topics of a filing, such as updates on NRC engagement, manufacturing agreements with partners like ATB Riva Calzoni, or changes in capital structure following a business combination. The platform also surfaces insider transaction reports on Form 4, proxy materials on executive and board matters when available, and other SEC forms that contribute to a fuller picture of NKLR’s regulatory and corporate history.
By combining real-time EDGAR updates with concise AI explanations, this page helps investors, analysts, and researchers navigate Terra Innovatum’s SEC filings and understand how its disclosures relate to the development of the SOLO micro-modular reactor.
Terra Innovatum Global N.V. reports that its audit committee dismissed MaloneBailey, LLP as independent auditor and appointed KPMG Accountants N.V. on
MaloneBailey’s prior audit report on the company’s financial statements as of
Terra Innovatum Global N.V. filed an amended report to correct typographical errors, mainly increasing Mr. Marco Cherubini’s subsidiary-level bonus from EUR 16,832.00 to EUR 116,832.00 and removing duplicate table entries. The board’s Remuneration Committee approved new directorship agreements for Alessandro Petruzzi (CEO), Massimo Morichi (Chief Strategy Officer) and Cesare Frepoli (Chief Operating Officer), setting fixed compensation for 2025 and 2026 and confirming that bonuses will depend on separate performance criteria.
The agreements run for one year, with annual renewals, and include termination rights, intellectual property ownership by the company, non-disparagement, and 12‑month non-solicitation clauses. In a change in control combined with certain terminations, each manager could receive a lump sum equal to 18 months of fixed pay plus target bonus, a pro-rated current-year bonus, extended healthcare for 18 months and potential equity vesting benefits. The committee also approved one-time subsidiary-level bonuses and additional payments for several officers and a related entity, in both euros and U.S. dollars, to recognize the successful business combination and Nasdaq listing.
Terra Innovatum Global N.V. is registering up to 140,480,029 Terra Shares for resale, plus up to 5,475,593 Ordinary Shares issuable upon exercise of outstanding warrants and up to 40,200,000 Ordinary Shares issuable upon mandatory conversion of preferred shares. The resale shares include stock held by the SPAC sponsor, management, advisors, bridge loan lenders and PIPE investors following Terra’s business combination with GSR III Acquisition Corp.
The company will not receive proceeds from any shareholder resales, but could receive up to approximately $59.5 million if all warrants are exercised for cash, which it intends to use for general corporate and working capital purposes. Terra develops the SOLO micro modular nuclear reactor and has not yet generated revenue, reports operating losses and discloses substantial doubt about its ability to continue as a going concern, alongside significant regulatory, technological, market adoption and supply-chain risks. The filing warns that full resale of the registered shares could materially pressure the trading price of Terra’s stock.
Terra Innovatum Global N.V. (NKLR) filed a Form 8-K to announce that, on November 20, 2025, it issued a press release about signing a letter of intent with a customer. The filing treats this as a Regulation FD disclosure and furnishes the press release as Exhibit 99.1 rather than filing it, meaning it is not automatically incorporated into other securities law filings. The company also includes standard forward-looking statement language, emphasizing that expectations about future operating results, strategy, and growth are subject to significant risks and uncertainties described in its periodic SEC reports.